cryptolepine has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angenot, L; Bailly, C; Bonjean, K; Colson, P; Dassonneville, L; De Pauw-Gillet, MC; Defresne, MP; Greimers, R; Houssier, C; Quetin-Leclercq, J; Tits, M; Wright, C | 1 |
| Bailly, C; Baldeyrou, B; Cimanga, K; Colson, P; De Pauw-Gillet, MC; Houssier, C; Laine, W; Pieters, L; Van Miert, S; Vlietinck, AJ | 1 |
2 other study(ies) available for cryptolepine and B16 Melanoma
| Article | Year |
|---|---|
The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells.
Topics: Alkaloids; Animals; Antineoplastic Agents; Base Sequence; DNA Footprinting; DNA, Neoplasm; Dose-Response Relationship, Drug; Indole Alkaloids; Indoles; Intercalating Agents; Melanoma, Experimental; Mice; Molecular Sequence Data; Nucleic Acid Denaturation; Quinolines; Spectrum Analysis; Topoisomerase II Inhibitors | 1998 |
DNA intercalation, topoisomerase II inhibition and cytotoxic activity of the plant alkaloid neocryptolepine.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Cattle; Circular Dichroism; DNA; DNA Damage; DNA Footprinting; DNA Topoisomerases, Type II; Humans; Indole Alkaloids; Indoles; Intercalating Agents; KB Cells; Melanoma, Experimental; Mice; Mice, Inbred Strains; Plant Roots; Plants, Medicinal; Quinolines; Substrate Specificity; Topoisomerase II Inhibitors | 2000 |